atropine 2.1 MG / pralidoxime Cl 600 MG Auto-Injector
- RxCUI
- 727415
- RxNorm name
- atropine 2.1 MG / pralidoxime Cl 600 MG Auto-Injector
- Display name
- atropine 2.1 MG / pralidoxime Cl 600 MG Auto-Injector
- Full name
- atropine 2.1 MG / pralidoxime Cl 600 MG Auto-Injector
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:50
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ATNAA atropine and pralidoxime chloride Auto-Injector | ATROPINE AND PRALIDOXIME CHLORIDE | Meridian Medical Technologies, LLC | 596c7a8f-27cd-4de2-9491-476f43570b8b | 2022-07-18 | Warnings, Adverse reactions | 727415 |
| DuoDote | ATROPINE AND PRALIDOXIME CHLORIDE | Meridian Medical Technologies LLC | 241f42a0-1a33-40e8-8221-201767d999e5 | 2022-04-04 | Warnings, Adverse reactions | 727415 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 241f42a0-1a33-40e8-8221-201767d999e5 | atropine 2.1 MG / pralidoxime Cl 600 MG Auto-Injector [PSN] · 2.7 ML atropine 0.778 MG/ML / pralidoxime chloride 222 MG/ML Auto-Injector [SCD] · atropine 2.1 MG / pralidoxime chloride 600 MG Auto-Injector [SY] | 3 | 17 | These highlights do not include all the information needed to use DUODOTE ® safely and effectively. See full prescribing information for DUODOTE. DUODOTE (atropine and pralidoxime chloride injection), for intramuscular use Initial U.S. Approval: 2006 | 20220404 |
| 596c7a8f-27cd-4de2-9491-476f43570b8b | atropine 2.1 MG / pralidoxime Cl 600 MG Auto-Injector [PSN] · 2.7 ML atropine 0.778 MG/ML / pralidoxime chloride 222 MG/ML Auto-Injector [SCD] · atropine 2.1 MG / pralidoxime chloride 600 MG Auto-Injector [SY] | 3 | 11 | These highlights do not include all the information needed to use ATNAA safely and effectively. See full prescribing information for ATNAA. ATNAA (atropine and pralidoxime chloride injection), for intramuscular use Initial U.S. Approval: 2002 | 20220718 |